Beaten-Down Biotech Just Lost a Backer — Should You Care
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Compare which total market fund to hold in retirement in 2024 and how to balance it with other assets. Focus on cost, tax efficiency, and diversification.
28,509 articlesWhen a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
As AI expands from novelty to durable demand, investors wonder if the AI trade is entering its second wave. This arti...
Oracle’s massive debt problem isn’t just a headline. In this guide, we break down the debt load, its possible payback...
BridgeBio's Q1 2026 earnings narrative is more than quarterly numbers—it's a roadmap for the year ahead. This guide e...
Real estate can grow wealth or burn it, depending on where you buy. Learn which markets pose the biggest risks, the s...
The housing market is a split landscape in March 2026: some areas surge with demand while others cool after sharp cor...
A wave of weaker confidence is reshaping housing activity, even as the job market holds steady. This guide breaks dow...
MIAX is shaping 2026 in a dynamic way, and the first-quarter earnings transcript offers clues about growth drivers an...
When markets tank, investors ask which asset holds up better. This article compares XRP and Shiba Inu to help you dec...
Arm Holdings sparked a rally as investors eyed its AI push and the Arm Everywhere event. This article breaks down why...
A Bernstein Research note argues Bitcoin has likely formed a cycle bottom and pins a $450 target on Strategy stock, s...